Cardia Bioplastics has expanded its patent portfolio with 19 granted patents apart from 42 more pending registrations for its bioplastics technology.
The company has also secured seven new Cardia Compostable, Biohybrid and PPC-starch technology patents in Japan, Australia, New Zealand and China in 2014.
About seven new patents have been granted to the company for its bioplastics resin formulations and production processes.
With these new patents, Cardia Bioplastics has expanded its intellectual property portfolio of 11 patent families, with 19 patents so far granted in USA, Australia, China, Japan, New Zealand and South Africa.
The patents will help to protect the composition formulation and manufacturing process that has been invented by Cardia's R&D team.
Cardia Bioplastics managing director Frank Glatz said: "This marks an important milestone for Cardia Bioplastics. These granted patents protect the intellectual property of the Company and further support the technical differentiation of our globally certified Cardia Compostable and independently validated lower carbon foot print Cardia Biohybrid product offering.
"Cardia is collaborating with leading global brand owners to reduce the environmental impact of their packaging. Cardia's Biohybrid technology enables them to reduce the carbon footprint and the use of less oil in their packaging with an environmental benefit whilst maintaining product performance."
Cardia Bioplastics chairman Richard Tegoni said: "Protecting Cardia's intellectual property is a high priority as it supports our businesses long-term growth strategy of creating new Compostable and Biohybrid resins that meet the needs of the growing market for resins and finished products."
Image: Yoghurt Containers made from Cardia Biohybrid technology, now patent protected. Photo: courtesy of Cardia Bioplastics.
